Press Releases

Sixth-Annual Pharmacy Patient Choice Awards Winners

November

03

MMIT Announces Winners of the Sixth-Annual Specialty Pharmacy Patient Choice Awards

Winners in each of the four categories were announced at a virtual awards ceremony on Tuesday, Nov. 2.

Nov. 3, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—has announced the winners of the sixth-annual Specialty Pharmacy Patient Choice Awards.

MMIT hosted a virtual awards ceremony on Tuesday, Nov. 2, to honor the recipients. The finalists and winners in each category are:

Hospital and Health System Specialty Pharmacy
Winner: Vanderbilt Health
Finalists: Parkview Health, Summa Health, Monument Health

Independent Specialty Pharmacy
Winner: PANTHERx Rare Pharmacy
Finalists: Onco360, Parkway Specialty Pharmacy, Senderra Specialty Pharmacy

Payer/PBM Specialty Pharmacy
Winner: Humana
Finalists: AcariaHealth, CVS, Welldyne Specialty Pharmacy (US Specialty)

Retail Specialty Pharmacy
Winner: Publix
Finalists: H-E-B, Costco, Sam’s Club

The finalists and winners are calculated based on the highest average Net Promoter Score (NPS) from the Zitter Insights Specialty Pharmacy Patient Satisfaction Survey, which provides clients with data they can trust to help them improve patient satisfaction and increase scripts. NPS is a well-established research method that measures customer satisfaction.

“Amid a tumultuous year for healthcare, these specialty pharmacies rose to the top with their steadfast dedication to patients,” said MMIT CEO Mike Gallup. “This recognition is very well-deserved. Congratulations to Vanderbilt Health, PANTHERx, Humana and Publix.”

Learn more about MMIT’s specialty pharmacy solutions

Featured
Emerging-Treatments-Offer-New-Hope-Alcohol-Use-Disorder

Emerging Treatments Offer New Hope for Alcohol Use Disorder

Key-Takeaways-Rare-Disease-Commercialization

Competitive ATTR Dynamics: Key Takeaways for Rare-Disease Commercialization

Alternative-Funding-Programs

Alternative Funding Programs: Short-Term Savings, Long-Term Consequences

Topics
Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch